BioTime Opens Asian Subsidiary to Sell Stem Cell Tools, Therapies

(Stem Cells News image)

Stem-cell firm BioTime said this week that it will open a subsidiary in China called BioTime Asia to expand its stem cell therapeutics and research tools to the Asian market.

BioTime Asia will be based at the Nanshan Memorial Medical Institute, or NSMMI, and will clinically develop and market therapeutic stem cell products in China and market stem cell research products in China and other Asian countries (…)

BioTime and its US research tools subsidiary, Embryome Sciences, will license the rights to certain stem cell technology to BioTime Asia, and will sell the Chinese subsidiary stem cell products for therapeutic use and for resale as research products, BioTime said. Under the arrangement, BioTime Asia will license back to BioTime any new technology it might develop or acquire for use outside of China (…)


Reblog this post [with Zemanta]

3 thoughts on “BioTime Opens Asian Subsidiary to Sell Stem Cell Tools, Therapies”

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.